Companies
HQNew York
Employees11-50
Funding$142M
3 active roles
AI / MLFoundation Model ProviderB2B SaaSSeed$50M-$200M
About
EvolutionaryScale develops frontier AI models for protein design, enabling simultaneous reasoning over sequence, structure, and function. It markets AI protein-design tools via API access to biotech and pharmaceutical researchers. The company’s differentiators include its ESM3 language model and related Cambrian family, designed for biology-specific AI applications.
Active Roles
3Key Investors
Lux Capital, Nat Friedman, Daniel Gross, Amazon, NVentures